Singapore and Auckland, New Zealand, 17 February 2023: Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce that its portfolio therapy to treat rare soft tissue sarcomas has now been approved in New Zealand.
- Welcome to Specialised Therapeutics
-
SE Asia (HQ)
+65 3158 9940
-
Australia
1300 798 820
-
New Zealand
+64 9801 0299
cholangiocarcinoma - Specialised Therapeutics
February 17, 2023
January 20, 2023
New Therapy to Treat Rare Gastrointestinal Stromal Tumour Approved for New Zealand Patients
Singapore and New Zealand, 20 January 2023: Independent biopharmaceutical company Specialised Therapeutics Asia (ST) is pleased to announce that a new therapy to treat rare gastrointestinal stromal tumour (GIST) shown to improve survival has now been approved in New Zealand.
September 16, 2022
New Treatment for Rare Cancer Cholangiocarcinoma Approved in Australia
Melbourne, Australia 15 September 2022: A NEW targeted therapy to treat a rare bile duct cancer called cholangiocarcinoma has been approved for use in Australia.